Aurobindo gets FDA approval for potassium chloride extended release tablets
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application potassium chloride extended-release tablets USP, 10 mEq, 15 mEq, and 20 mEq. Aurobindo Pharma’s potassium chloride extended release tablets, are an AB-rated generic equivalent to the reference listed drug (RLD), potassium chloride extended
